Clinical trial
Clinical Study on Reducing Myocardial Infarction Siez After Primary PCI in Patients With ST Segment Elevation Myocardial Infarction by Using Henagliflozin
NCT06187727 is registered in ClinicalTrials.gov with Qian geng as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study on Reducing Myocardial Infarction Siez After Primary PCI in Patients With ST Segment Elevation Myocardial Infarction by Using Henagliflozin
- Lead sponsor
- Qian geng
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 1, 2023
- Completion date
- October 1, 2025
- Enrollment
- 248 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.